Eric K. Nguyen Data-verified
Affiliation confirmed via AI analysis of OpenAlex, ORCID, and web sources.
Researcher
faculty
Research Areas
Links
Biography and Research Information
OverviewAI-generated summary
Eric K. Nguyen's research focuses on the application and outcomes of stereotactic body radiation therapy (SBRT) and hypofractionated stereotactic radiotherapy. His work includes investigating the long-term safety and efficacy of these treatments for various oncological conditions, such as benign intracranial meningiomas, spine metastases, and non-spine bone metastases. Nguyen also examines predictors of treatment complications like pathologic fracture and local recurrence, and analyzes the utilization of SBRT in clinical settings. His studies have explored treatment strategies for metastatic renal cell carcinoma and thoracic cancers, as well as pain relief for bone metastases. Nguyen has published 37 papers, with an h-index of 7 and 209 total citations. He collaborates with researchers at the University of Central Arkansas, including Andrew Johns and Jeremy Abbott.
Metrics
- h-index: 7
- Publications: 37
- Citations: 214
Selected Publications
-
Efficient Self-Driving: A Study on the Behavioral Cloning based Autonomous Navigation (2025)
Collaboration Network
Top Collaborators
- Outcomes of Radiation Therapy Plus Immunotherapy in Metastatic Renal Cell Carcinoma: Results From the Canadian Kidney Cancer Information System
- Stereotactic body radiotherapy for osseous low alpha–beta resistant metastases for pain relief—SOLAR-P
- Stereotactic Body Radiotherapy for Osseous Low Alpha-Beta Resistant Metastases for Pain Relief – SOLAR-P
- Stereotactic body radiotherapy for spine metastases: a review of 24 Gy in 2 daily fractions
- Predictors of pathologic fracture and local recurrence following stereotactic body radiation therapy to 505 non-spine bone metastases
- Planning for the Effect of the SC.24 Trial on Spine Stereotactic Body Radiation Therapy Utilization at a Tertiary Cancer Center
- Stereotactic body radiotherapy for osseous low alpha–beta resistant metastases for pain relief—SOLAR-P
- Stereotactic Body Radiotherapy for Osseous Low Alpha-Beta Resistant Metastases for Pain Relief – SOLAR-P
- Stereotactic body radiotherapy for osseous low alpha–beta resistant metastases for pain relief—SOLAR-P
- Stereotactic Body Radiotherapy for Osseous Low Alpha-Beta Resistant Metastases for Pain Relief – SOLAR-P
- Multi-Target Thoracic Stereotactic Body Radiotherapy – Toxicity and Efficacy Analysis
- Stereotactic Body Radiation Therapy for Non-Spine Bone Metastases: Local Control and Fracture Risk
- Multi-Target Thoracic Stereotactic Body Radiotherapy – Toxicity and Efficacy Analysis
- Stereotactic Body Radiation Therapy for Non-Spine Bone Metastases: Local Control and Fracture Risk
- Predictors of pathologic fracture and local recurrence following stereotactic body radiation therapy to 505 non-spine bone metastases
- Stereotactic Body Radiation Therapy for Non-Spine Bone Metastases: Local Control and Fracture Risk
- Predictors of pathologic fracture and local recurrence following stereotactic body radiation therapy to 505 non-spine bone metastases
- Toxicity and Efficacy of Multitarget Thoracic Stereotactic Body Radiation Therapy
- Predictors of pathologic fracture and local recurrence following stereotactic body radiation therapy to 505 non-spine bone metastases
- Toxicity and Efficacy of Multitarget Thoracic Stereotactic Body Radiation Therapy
- Predictors of pathologic fracture and local recurrence following stereotactic body radiation therapy to 505 non-spine bone metastases
- Toxicity and Efficacy of Multitarget Thoracic Stereotactic Body Radiation Therapy
- Predictors of pathologic fracture and local recurrence following stereotactic body radiation therapy to 505 non-spine bone metastases
- Toxicity and Efficacy of Multitarget Thoracic Stereotactic Body Radiation Therapy
- Predictors of pathologic fracture and local recurrence following stereotactic body radiation therapy to 505 non-spine bone metastases
- Toxicity and Efficacy of Multitarget Thoracic Stereotactic Body Radiation Therapy
- Predictors of pathologic fracture and local recurrence following stereotactic body radiation therapy to 505 non-spine bone metastases
- Planning for the Effect of the SC.24 Trial on Spine Stereotactic Body Radiation Therapy Utilization at a Tertiary Cancer Center
- Stereotactic body radiotherapy for spine metastases: a review of 24 Gy in 2 daily fractions
- Predictors of pathologic fracture and local recurrence following stereotactic body radiation therapy to 505 non-spine bone metastases
- Stereotactic body radiotherapy for osseous low alpha–beta resistant metastases for pain relief—SOLAR-P
Similar Researchers
Based on overlapping research topics